Did You Know

Patients with heart disease or diabetes were more likely than those without the conditions to remain on statin therapy, according to a study. Among patients without heart disease or diabetes, those who were most likely to continue taking statins were overweight/obese or former smokers. The researchers also found that heavy …

Among patients with coronary artery disease, those who have both chronic kidney disease and type 2 diabetes face a significantly increased risk of cardiovascular events, compared with those who have either condition separately. The researchers found that the risk of cardiovascular events was significantly higher in patients with type 2 …

The new guidelines divide patients into four groups for whom statin treatment is recommended: individuals with cardiovascular disease; individuals with LDL cholesterol (LDL-C) levels higher than 190 mg/dL; individuals with diabetes, between the ages of 40-75, with LDL-C levels 70-189 mg/dL; and individuals without diabetes or cardiovascular disease, with LDL-C …

Vitamin D supplementation increased nutrient levels in patients with prediabetes in a recent study but patients in the supplement arm did not show better insulin sensitivity or beta cell function than those in the placebo cohort, researchers said. In a randomized controlled trial that showed vitamin D levels indeed rose …

In the U.S., 56% of uninsured patients are now eligible for financial assistance with insurance coverage through Medicaid, the Children’s Health Insurance Program, or subsidized private coverage under the Affordable Care Act, according to a new report. The analysis estimates the ACA ultimately will lead to more than 27 million …

According to new research, patients who review physicians online tend to be overwhelmingly positive: 56.8% give their physicians four stars (out of five) or better. But not all patients are as happy with their physicians. Below are the 10 happiest and 10 unhappiest cities in the Happy Patient Index. Happiest: …

A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world’s most widely used anti-diabetic drug, slows aging and increases lifespan. In the experiments, the researchers tease out the mechanism behind metformin’s age-slowing effects: the drug causes an increase in the …

The European Commission has approved empagliflozin 10 mg and 25 mg once-daily tablets for use in adults when glycemic control is not achieved from diet and exercise. The European Commission endorsed empagliflozin for approval in March after the U.S. FDA delayed the approval and requested more data. A new drug …

Technologies like interactive games and virtual reality platforms can help people with type 2 diabetes make better choices and monitor their health on a regular basis. The authors found that when people engage in interactive social platforms that are capable of building and hosting online therapeutic communities, they develop empathy …

For patients with type 2 diabetes, two large meals (breakfast and lunch) may be better than six small meals with the same total calories. Hana Kahleová from the Institute for Clinical and Experimental Medicine in Prague, Czech Republic said, "Eating only breakfast and lunch reduced body weight, liver fat content, …